LONDON, Oct. 8 (UPI) -- Pharmaceutical giant GlaxoSmithKline in London Monday announced the appointment of Andrew Witty as chief executive officer-designate.
Witty, currently president of GlaxoSmithKline's pharmaceuticals-Europe division, will succeed Jean-Pierre Garnier when he retires as CEO in May 2008, the company said in a news release.
Advertisement
"The board is confident that Andrew will build on JP’s considerable achievements which have positioned GSK as a leader of the pharmaceutical industry," Christopher Gent, Chairman, GlaxoSmithKline chairman said.